Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment

Lancet

Volumn 355, Issue 9204, 2000, Pages 610-613

  Cutfield, Wayne S ^a   Wilton, Patrick ^b   Bennmarker, Helge ^b   Albertsson Wikland, Kerstina ^c   Chatelain, Pierre ^d   Ranke, Michael B ^e   Price, David A ^f  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b PFIZER INC   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d Service de Pediatrie Lyon   (France)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOSE; GROWTH HORMONE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; HORMONAL THERAPY; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 0034685191     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04055-6     Document Type: Article

References (22)

1. Shizume K. Long term effects of human growth hormone on 1,959 patients with pituitary dwarfism throughout Japan. Endocrinol Jpn. 31:1984;201-206.
2. Czernichow P. Growth hormone administration and carbohydrate metabolism. Horm Res. 39:1993;102-103.
3. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
4. Freeman J.V., Cole T.J., Chinn S., Jones P.R.M., White E.M., Preece M.A. Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 73:1995;17-24.
5. Green A., Gale E.A., Patterson C.C. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet. 339:1992;905-909.
6. Neu A., Kehrer M., Hub R., Ranke M.B. Incidence of IDDM in German children aged 0-14 years. Diabetes Care. 20:1997;530-533.
7. Kitagawa T., Owada M., Urakami T., Tajima N. Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Pract. 24:1994;7-13. (suppl).
8. Rangasami J.J., Greenwood D.C., McSporran B., Smail P.J., Patterson C.C., Waugh N.R. Rising incidence of type 1 diabetes in Scottish children, 1984-93. Arch Dis Child. 77:1997;210-213.
9. Verge C.F., Silink M., Howard N.J. The incidence of childhood IDDM in New South Wales, Australia. Diabetes Care. 17:1994;693-696.
10. Karvonen M., Tuomilehto J., Libman I., LaPorte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;883-892.
11. Rewers M., LaPorte R.E., King H., Tuomilehto J. Trends in the prevalence and incidence of diabetes: insulin-dependent diabetes mellitus in childhood. World Health Stat Q. 41:1988;179-189.
12. Gardner S., Bingley P., Sawtell P., Weeks S., Gale E.A. Rising incidence of insulin dependent diabetes mellitus in children aged 5 years in the Oxford region; time trend analysis. BMJ. 315:1997;713-717.
13. Pinhas-Hamiel O., Dolan L.M., Daniels S.R., Standiford D., Khoury P.R., Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 128:1996;608-615.
14. Blethen S.L., Allen D.B., Graves D., August G., Moshang T., Rosenfeld R. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab. 81:1996;1704-1710.
15. Smith T.R., Elmendorf J.S., David T.S., Turinsky J. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1 and GLUT-4. Am J Physiol. 272:1997;1071-1079.
16. Jadresic A., Banks L.M., Child D.F.et al. The acromegaly syndrome. Q J Med. 51:1982;189-204.
17. Wass J.A., Cudworth A.G., Bottazzo G.F., Woodrow J.C., Besser G.M. An assessment of glucose intolerance in acromegaly and its response to medical treatment. Clin Endocrinol (Oxf). 12:1980;53-59.
18. Bougneres P.F. High-dose growth hormone treatment of non-growth hormone-deficient children: preliminary results after 2 years. Acta Paediatr Scand Suppl. 366:1990;38-41.
19. Hofman P.L., Cutfield W.S., Robinson E.M.et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab. 82:1997;402-406.
20. Caprio S., Boulware D., Tamborlane V. Growth hormone and insulin interactions. Horm Res. 38:1992;47-49. (suppl 2).
21. Amiel S.A., Sherwin R.S., Simonson D.C., Lauritano A.A., Tamborlane W.V. Impaired insulin action in puberty. N Engl J Med. 315:1986;215-219.
22. Cutfield W.S., Bergman R.N., Menon R.K., Sperling M.A. The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab. 70:1990;1644-1650.